Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A novel inhibitor of human cytomegalovirus acts through a specific antiviral mechanism that involves the helicase-primase complex.
Journal: Antimicrobial agents and chemotherapy
Published: July 13, 2026
ZFAND6 promotes TRAF2-dependent mitophagy to restrain cGAS-STING signaling.
Journal: iScience
Published: August 02, 2024
Artemisinins target the intermediate filament protein vimentin for human cytomegalovirus inhibition.
Artemisinins target the intermediate filament protein vimentin for human cytomegalovirus inhibition.
Journal: The Journal of biological chemistry
Published: April 29, 2020
Validation and Characterization of Five Distinct Novel Inhibitors of Human Cytomegalovirus.
Journal: Journal of medicinal chemistry
Published: March 20, 2020
Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic Ozonides.
Journal: Antimicrobial agents and chemotherapy
Published: August 15, 2018
Role of nucleotide-binding oligomerization domain 1 (NOD1) and its variants in human cytomegalovirus control in vitro and in vivo.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 19, 2016
Inhibition of human cytomegalovirus replication by artemisinins: effects mediated through cell cycle modulation.
Journal: Antimicrobial agents and chemotherapy
Published: February 03, 2015
In vitro combination of anti-cytomegalovirus compounds acting through different targets: role of the slope parameter and insights into mechanisms of Action.
Journal: Antimicrobial agents and chemotherapy
Published: November 27, 2013
Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication.
Journal: PloS one
Published: November 23, 2013
Wnt modulating agents inhibit human cytomegalovirus replication.
Journal: Antimicrobial agents and chemotherapy
Published: April 11, 2013
Human cytomegalovirus inhibition by cardiac glycosides: evidence for involvement of the HERG gene.
Journal: Antimicrobial agents and chemotherapy
Published: July 11, 2012
Last Updated: 09/26/2026